Want to see JP:2689 full AI Analyst Report?
Top Page
OLBA HEALTHCARE HOLDINGS, Inc.
(2689)
Select Model
Select Model
Rating:62Neutral
Price Target:
¥2,015.00
▼(-1.47% Downside)
Action:Reiterated
Date:08/17/26
The score is driven primarily by mixed financial quality: rapid sales growth and a conservative balance sheet are offset by thin/declining margins and negative free cash flow in 2026. Valuation is a clear positive (low P/E and strong dividend yield), but weak technicals (below key moving averages and negative MACD) limit the overall score.
Positive Factors
Accelerating Revenue Growth
The sharp 2026 revenue increase indicates strong demand, expanded distribution activity, or improved market penetration. Sustained top-line momentum can support operating scale and strengthen the company’s competitive position if profitability is restored.
Negative Factors
Thin and Declining Margins
Very low and weakening margins leave limited protection against supplier costs, labor expense, pricing pressure, or unfavorable product mix. Continued compression could prevent strong revenue growth from translating into durable earnings and internal cash generation.
Read all positive and negative factors
Positive Factors
Negative Factors
Accelerating Revenue Growth
The sharp 2026 revenue increase indicates strong demand, expanded distribution activity, or improved market penetration. Sustained top-line momentum can support operating scale and strengthen the company’s competitive position if profitability is restored.
Read all positive factors
OLBA HEALTHCARE HOLDINGS, Inc. (2689) vs. iShares MSCI Japan ETF (EWJ)
Market Cap
¥11.39B
Dividend Yield4.27%
Average Volume (3M)2.71K
Price to Earnings (P/E)10.0
Beta (1Y)0.14
Revenue Growth3.17%
EPS Growth-22.27%
CountryJP
Employees1,393
SectorGeneral
Sector StrengthN/A
IndustryMedical - Distribution
Share Statistics
EPS (TTM)187.68
Shares Outstanding6,250,000
10 Day Avg. Volume2,760
30 Day Avg. Volume2,706
Financial Highlights & Ratios
PEG Ratio-0.45
Price to Book (P/B)0.86
Price to Sales (P/S)0.09
P/FCF Ratio-29.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
OLBA HEALTHCARE HOLDINGS, Inc. Business Overview & Revenue Model
Company Description
OLBA HEALTHCARE HOLDINGS, Inc., founded in 1921 and based in Okayama, Japan, provides an extensive range of healthcare and life science solutions to a diverse clientele across the country. Its customers include medical facilities, academic institu...
OLBA HEALTHCARE HOLDINGS, Inc. Financial Statement Overview
Summary
Income Statement
66
Positive
Balance Sheet
78
Positive
Cash Flow
44
Neutral
| Breakdown | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 126.60B | 122.70B | 118.56B | 110.47B | 107.96B |
| Gross Profit | 14.18B | 13.91B | 13.60B | 12.95B | 12.50B |
| EBITDA | 2.42B | 2.59B | 2.83B | 2.68B | 2.56B |
| Net Income | 1.11B | 1.43B | 1.50B | 1.41B | 1.54B |
Balance Sheet | |||||
| Total Assets | 46.65B | 45.87B | 43.24B | 40.88B | 39.97B |
| Cash, Cash Equivalents and Short-Term Investments | 2.64B | 3.47B | 2.73B | 2.40B | 3.19B |
| Total Debt | 2.89B | 2.95B | 1.63B | 1.92B | 1.28B |
| Total Liabilities | 33.59B | 33.62B | 31.86B | 30.55B | 30.88B |
| Stockholders Equity | 13.06B | 12.26B | 11.37B | 10.33B | 9.09B |
Cash Flow | |||||
| Free Cash Flow | -388.56M | 181.25M | 1.61B | -910.52M | 1.97B |
| Operating Cash Flow | 864.57M | 1.63B | 2.08B | -659.52M | 2.42B |
| Investing Cash Flow | -1.11B | -1.64B | -673.03M | -306.25M | -211.81M |
| Financing Cash Flow | -590.53M | 686.95M | -1.09B | 175.94M | -1.17B |
OLBA HEALTHCARE HOLDINGS, Inc. Technical Analysis
Negative
2045.00
Price Trends
1911.20
Negative
1952.29
Negative
1973.79
Negative
Market Momentum
-13.09
Positive
33.90
Neutral
10.70
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:2689, the sentiment is Negative. The current price of 2045 is above the 20-day moving average (MA) of 1892.35, above the 50-day MA of 1911.20, and above the 200-day MA of 1973.79, indicating a bearish trend. The MACD of -13.09 indicates Positive momentum. The RSI at 33.90 is Neutral, neither overbought nor oversold. The STOCH value of 10.70 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:2689.
OLBA HEALTHCARE HOLDINGS, Inc. Peers Comparison
UnderperformOutperform
Sector (55)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ¥46.04B | 11.30 | ― | 2.63% | 5.16% | 37.79% | |
66 Neutral | ¥9.57B | 14.44 | ― | 1.87% | -0.52% | 3.87% | |
64 Neutral | ¥40.60B | 13.07 | ― | 0.91% | 6.17% | -33.01% | |
62 Neutral | ¥11.39B | 9.98 | ― | 3.90% | 3.17% | -22.27% | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% | |
52 Neutral | ¥14.14B | 19.27 | ― | 1.83% | 2.87% | -73.55% |
* General Sector Average
JP:2689
OLBA HEALTHCARE HOLDINGS, Inc.
1,871.00
-71.48
-3.68%
JP:3417
Ohki Health Care Holdings, Inc.
1,032.00
-250.73
-19.55%
JP:6062
Charm Care Corporation
1,404.00
380.24
37.14%
JP:7071
Amvis Holdings.Inc.
417.00
-214.82
-34.00%
JP:9265
YAMASHITA HEALTH CARE HOLDINGS, INC.
3,745.00
768.71
25.83%
OLBA HEALTHCARE HOLDINGS, Inc. Corporate Events
OLBA Healthcare Profit Slips as Balance Sheet Strengthens Ahead of DVx Integration
Aug 12, 2026
OLBA Healthcare Holdings reported consolidated net sales of ¥126,595 million for the fiscal year ended June 30, 2026, up 3.2% year on year, while operating profit fell 15.2% to ¥1,679 million and profit attributable to owners of the pare...
OLBA Healthcare and DVx to Merge via Share Exchange Amid Mounting Sector Pressures
May 22, 2026
OLBA HEALTHCARE HOLDINGS and DVx Inc. have agreed to a business integration via a share exchange that will make OLBA HEALTHCARE the wholly owning parent and DVx its wholly owned subsidiary, with the transaction scheduled to take effect on Septembe...
OLBA Sets Record Date for Vote on DVx Business Integration
May 22, 2026
OLBA HEALTHCARE HOLDINGS, Inc. has set June 8, 2026, as the record date to determine shareholders eligible to vote at an upcoming extraordinary general meeting. The company will provide notice electronically via its website, establishing which inv...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.